Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Clover Health Investments...

    NASDAQ: CLOV · Real-Time Price · USD
    3.13
    0.00 (0.00%)
    At close: May 29, 2025, 3:59 PM
    3.12
    -0.46%
    After-hours: May 29, 2025, 07:59 PM EDT
    0.00%
    Bid 3.1
    Market Cap 1.6B
    Revenue (ttm) 1.49B
    Net Income (ttm) -25.11M
    EPS (ttm) -0.04
    PE Ratio (ttm) -78.37
    Forward PE -160
    Analyst Buy
    Ask 3.16
    Volume 4,588,953
    Avg. Volume (20D) 6,082,177
    Open 3.15
    Previous Close 3.13
    Day's Range 3.09 - 3.21
    52-Week Range 0.90 - 4.87
    Beta 2.00

    About CLOV

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CLOV
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CLOV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 weeks ago
    +12.54%
    Clover Health Investments shares are trading highe... Unlock content with Pro Subscription
    3 months ago
    -4.11%
    Clover Health Investments shares are trading lower after the company reported a Q4 sales and revenue miss.
    news image

    2 weeks ago · zacks.com

    All You Need to Know About Clover Health Investments (CLOV) Rating Upgrade to Strong Buy

    Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

    news image

    2 weeks ago · seekingalpha.com

    Clover Health: Stars Are Aligning For GAAP Profitability In FY 2026

    Clover reported impressive Q1 earnings with robust topline growth and improving profitability metrics thanks to a 30% YoY increase in its member base. Clover could see $95 million in additional revenu...

    news image

    3 weeks ago · zacks.com

    CLOV Stock Rises as Q1 Earnings Beat Estimates, Revenues Up Y/Y

    Clover Health's first-quarter 2025 results continue to benefit from the strength of its strong member retention. A decline in operating loss bodes well.

    news image

    3 weeks ago · seekingalpha.com

    Clover Health Investments, Corp. (CLOV) Q1 2025 Earnings Call Transcript

    Clover Health Investments, Corp. (NASDAQ:CLOV ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer Pete...

    news image

    3 weeks ago · zacks.com

    Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates

    Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.05 per share...

    news image

    3 weeks ago · zacks.com

    Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?

    MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.

    news image

    2 months ago · seekingalpha.com

    Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth

    Clover Health Investments' AI capabilities are a major driver for its topline and bottom-line improvements in FY 2024. Clover Health's MCR in Q4 represented a decline from Q3, unlike past years, and r...

    news image

    2 months ago · marketbeat.com

    Missed the Hims & Hers Rally? Clover Health Could Be Next

    Shares of Hims & Hers Health Inc. NYSE: HIMS have made a splash in recent weeks, reaching a new all-time high of just under $73 per share. However, a few days later, most of the upside moved right bac...

    news image

    3 months ago · zacks.com

    CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises

    Clover Health's fourth-quarter 2024 results continue to benefit from the strength of its strong member retention. Strong revenue outlook bodes well.

    Add to Watchlist